Download Files:
ALDH1A1-IN-2
SKU
HY-126003-10 mg
Category Reference compound
Tags Aldehyde Dehydrogenase (ALDH), Cancer, Metabolic Enzyme/Protease
$350 – $2,900
Products Details
Product Description
– ALDH1A1-IN-2 is a potent inhibitor of aldehyde dehydrogenase 1a1 (aldh1a1). Aldehyde dehydrogenases (ALDH) constitute a family of enzymes that play a critical role in oxidizing various cytotoxic xenogenic and biogenic aldehydes. ALDH1A1-IN-2 has the potential for the research of cancer, inflammation, or obesity (extracted from patent WO2019089626A1, compound 295)[1].
Web ID
– HY-126003
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C25H23ClN4O3S
References
– [1]Shyh Ming YANG, et al. Substituted quinoline analogs as aldehyde dehydrogenase 1a1 (aldh1a1) inhibitors. Patent WO2019089626A1.
CAS Number
– 2231081-18-6
Molecular Weight
– 494.99
Compound Purity
– 99.48
SMILES
– N#CC1(C2=CC=C(C3=C(C(N4CCN(S(=O)(C)=O)CC4)=O)C=NC5=CC=C(Cl)C=C35)C=C2)CC1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 1 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Aldehyde Dehydrogenase (ALDH)
Isoform
– ALDH1
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.